Evidence map›Paper›PMID 26739359›Full record

ArticleScientific reports2016

Mathematical modelling of transcriptional heterogeneity identifies novel markers and subpopulations in complex tissues.

Niya Wang, Eric P Hoffman, Lulu Chen, Li Chen, Zhen Zhang, Chunyu Liu, Guoqiang Yu, David M Herrington, Robert Clarke, Yue Wang

Abstract read
In one paragraph

Article in Scientific reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. CLINICAL HETEROGENEITY IN THE AGE OF BIG DATA, ADVANCED ANALYTICS, AND COMPLEXITY THEORY.Transactions of the American Clinical and Climatological Association · 2023
    Article
  13. FSCAM: CAM-Based Feature Selection for Clustering scRNA-seq.Interdisciplinary sciences, computational life sciences · 2022
    Article
  14. Article
  15. Article
  16. MRI Radiogenomics in Precision Oncology: New Diagnosis and Treatment Method.Computational intelligence and neuroscience · 2022
    Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Niya WangDepartment of Electrical and Computer Engineering, Virginia Polytechnic Institute and State University, Arlington, VA 22203, USA.
Eric P HoffmanResearch Center for Genetic Medicine, Children's National Medical Center, Washington, DC 20007, USA.
Lulu ChenDepartment of Electrical and Computer Engineering, Virginia Polytechnic Institute and State University, Arlington, VA 22203, USA.
Li ChenPediatric Oncology Branch, National Institutes of Health, Gaithersburg, MD 20877, USA.
Zhen ZhangDepartment of Pathology, Johns Hopkins University, Baltimore, MD 21231, USA.
Chunyu LiuDepartment of Psychiatry, University of Illinois at Chicago, Chicago, Illinois 60607, USA.
Guoqiang YuDepartment of Electrical and Computer Engineering, Virginia Polytechnic Institute and State University, Arlington, VA 22203, USA.
David M HerringtonDepartment of Medicine, Wake Forest University, Winston-Salem, NC 27157, USA.
Robert ClarkeLombardi Comprehensive Cancer Center, Georgetown University, Washington, DC 20057, USA.
Yue WangDepartment of Electrical and Computer Engineering, Virginia Polytechnic Institute and State University, Arlington, VA 22203, USA.

Funding

Genomic and Proteomic Architecture of AtherosclerosisR01HL111362 · NHLBI · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI HERRINGTON, DAVID MCLEOD · 2012 to 2021
$17.2M
Proteome Characterization Center: A Genoproteomics Pipeline for Cance ResearchU24CA160036 · NCI · JOHNS HOPKINS UNIVERSITY · PI CHAN, DANIEL WANYUI, ZHANG, HUI · 2011 to 2016
$10.7M
Improved Diagnostic of the Muscular DystrophiesR01NS029525 · NINDS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI HOFFMAN, ERIC P. · 1991 to 2015
$6.5M
Collaborative Research in Integrative Cancer BiologyU01CA184902 · NCI · GEORGETOWN UNIVERSITY · PI CLARKE, ROBERT R., WANG, YUE · 2014 to 2018
$2.7M
Uncovering Estrogen Receptor-Signaling Networks to Overcome Endocrine ResistanceR01CA149653 · NCI · VIRGINIA POLYTECHNIC INST AND ST UNIV · PI XUAN, JASON JIANHUA · 2011 to 2015
$1.5M
Integrating epigenomic maps to predict regulatory functions of genetic variantsR01ES024988 · NIEHS · UNIVERSITY OF ILLINOIS AT CHICAGO · PI LIU, CHUNYU · 2014 to 2015
$625k
NCI NIH HHS CA149653NCI NIH HHS CA160036NCI NIH HHS CA184902NCI NIH HHS R01 CA149653NCI NIH HHS U01 CA184902NCI NIH HHS U24 CA160036NHLBI NIH HHS HL111362NHLBI NIH HHS R01 HL111362NIEHS NIH HHS ES024988NIEHS NIH HHS R01 ES024988NINDS NIH HHS NS029525NINDS NIH HHS R01 NS029525
6 · The paper itself

Abstract

Tissue heterogeneity is both a major confounding factor and an underexploited information source. While a handful of reports have demonstrated the potential of supervised computational methods to deconvolute tissue heterogeneity, these approaches require a priori information on the marker genes or composition of known subpopulations. To address the critical problem of the absence of validated marker genes for many (including novel) subpopulations, we describe convex analysis of mixtures (CAM), a fully unsupervised in silico method, for identifying subpopulation marker genes directly from the original mixed gene expressions in scatter space that can improve molecular analyses in many biological contexts. Validated with predesigned mixtures, CAM on the gene expression data from peripheral leukocytes, brain tissue, and yeast cell cycle, revealed novel marker genes that were otherwise undetectable using existing methods. Importantly, CAM requires no a priori information on the number, identity, or composition of the subpopulations present in mixed samples, and does not require the presence of pure subpopulations in sample space. This advantage is significant in that CAM can achieve all of its goals using only a small number of heterogeneous samples, and is more powerful to distinguish between phenotypically similar subpopulations.

Indexed as

Models, BiologicalTranscriptomeAnimalsBiomarkersBrainGene Expression ProfilingGenes, FungalLiverLungOrgan SpecificityRatsYeastsBiomarkers

Identifiers

PMID26739359
PMCPMC4703969

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.